Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity

Eric J.Belin De Chantemèle, Mohammed Irfan Ali, James D. Mintz, William E. Rainey, Michel L. Tremblay, David J. Fulton, David W. Stepp

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Obesity is a major risk factor for hypertension. The copresentation of hypertension and insulin resistance (IR) suggests a role for IR in blood pressure (BP) dysregulation. To test this hypothesis, peripheral IR has been genetically subtracted in a model of obesity by crossing leptin receptor mutant mice (KdbHPTP) with mice lacking protein tyrosine phosphatase 1B (insulin desensitizer, HdbKPTP) to generate obese insulin-sensitive mice (KdbKPTP). BP was recorded in lean (HdbHPTP, HdbKPTP) and obese (KdbHPTP, KdbKPTP) mice via telemetry, and a frequency analysis of the recording was performed to determine BP variability. Correction of IR in obese mice normalized BP values to baseline levels (HdbHPTP: 116±2 mm Hg; KdbHPTP: 129±4 mm Hg; KdbKPTP: 114±5 mm Hg) and restored BP variability by decreasing its standard deviation and the frequency of BP values over the upper autoregulatory limit of the kidneys. However, although IR-induced increases in proteinuria (versus 53±13 μg/d, HdbHPTP) were corrected in KdbKPTP (112±39 versus 422±159 μg/d, KdbHPTP), glomerular hypertrophy was not. IR reduced plasma aldosterone levels ruling out a role for mineralocorticoids in the development of hypertension. Taken together, these data indicate that correction of IR prevents hypertension, BP variability, and microalbuminuria in obese mice. Although the mechanism remains to be fully determined, increases in aldosterone or sympathoactivation of the cardiovascular system seem to be less likely contributors.

Original languageEnglish (US)
Pages (from-to)1273-1279
Number of pages7
JournalHypertension
Volume60
Issue number5
DOIs
StatePublished - Nov 1 2012

Fingerprint

Non-Receptor Type 1 Protein Tyrosine Phosphatase
Insulin Resistance
Obesity
Blood Pressure
Hypertension
Obese Mice
Aldosterone
Insulin
Telemetry
Mineralocorticoids
Cardiovascular System
Proteinuria
Vascular Resistance
Hypertrophy
Kidney

Keywords

  • aldosterone
  • db/db mice
  • obese mice
  • pressure variability

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity. / De Chantemèle, Eric J.Belin; Ali, Mohammed Irfan; Mintz, James D.; Rainey, William E.; Tremblay, Michel L.; Fulton, David J.; Stepp, David W.

In: Hypertension, Vol. 60, No. 5, 01.11.2012, p. 1273-1279.

Research output: Contribution to journalArticle

@article{e02dd280ecb948f783a699c8e36dbc16,
title = "Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity",
abstract = "Obesity is a major risk factor for hypertension. The copresentation of hypertension and insulin resistance (IR) suggests a role for IR in blood pressure (BP) dysregulation. To test this hypothesis, peripheral IR has been genetically subtracted in a model of obesity by crossing leptin receptor mutant mice (KdbHPTP) with mice lacking protein tyrosine phosphatase 1B (insulin desensitizer, HdbKPTP) to generate obese insulin-sensitive mice (KdbKPTP). BP was recorded in lean (HdbHPTP, HdbKPTP) and obese (KdbHPTP, KdbKPTP) mice via telemetry, and a frequency analysis of the recording was performed to determine BP variability. Correction of IR in obese mice normalized BP values to baseline levels (HdbHPTP: 116±2 mm Hg; KdbHPTP: 129±4 mm Hg; KdbKPTP: 114±5 mm Hg) and restored BP variability by decreasing its standard deviation and the frequency of BP values over the upper autoregulatory limit of the kidneys. However, although IR-induced increases in proteinuria (versus 53±13 μg/d, HdbHPTP) were corrected in KdbKPTP (112±39 versus 422±159 μg/d, KdbHPTP), glomerular hypertrophy was not. IR reduced plasma aldosterone levels ruling out a role for mineralocorticoids in the development of hypertension. Taken together, these data indicate that correction of IR prevents hypertension, BP variability, and microalbuminuria in obese mice. Although the mechanism remains to be fully determined, increases in aldosterone or sympathoactivation of the cardiovascular system seem to be less likely contributors.",
keywords = "aldosterone, db/db mice, obese mice, pressure variability",
author = "{De Chantem{\`e}le}, {Eric J.Belin} and Ali, {Mohammed Irfan} and Mintz, {James D.} and Rainey, {William E.} and Tremblay, {Michel L.} and Fulton, {David J.} and Stepp, {David W.}",
year = "2012",
month = "11",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.112.196295",
language = "English (US)",
volume = "60",
pages = "1273--1279",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity

AU - De Chantemèle, Eric J.Belin

AU - Ali, Mohammed Irfan

AU - Mintz, James D.

AU - Rainey, William E.

AU - Tremblay, Michel L.

AU - Fulton, David J.

AU - Stepp, David W.

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Obesity is a major risk factor for hypertension. The copresentation of hypertension and insulin resistance (IR) suggests a role for IR in blood pressure (BP) dysregulation. To test this hypothesis, peripheral IR has been genetically subtracted in a model of obesity by crossing leptin receptor mutant mice (KdbHPTP) with mice lacking protein tyrosine phosphatase 1B (insulin desensitizer, HdbKPTP) to generate obese insulin-sensitive mice (KdbKPTP). BP was recorded in lean (HdbHPTP, HdbKPTP) and obese (KdbHPTP, KdbKPTP) mice via telemetry, and a frequency analysis of the recording was performed to determine BP variability. Correction of IR in obese mice normalized BP values to baseline levels (HdbHPTP: 116±2 mm Hg; KdbHPTP: 129±4 mm Hg; KdbKPTP: 114±5 mm Hg) and restored BP variability by decreasing its standard deviation and the frequency of BP values over the upper autoregulatory limit of the kidneys. However, although IR-induced increases in proteinuria (versus 53±13 μg/d, HdbHPTP) were corrected in KdbKPTP (112±39 versus 422±159 μg/d, KdbHPTP), glomerular hypertrophy was not. IR reduced plasma aldosterone levels ruling out a role for mineralocorticoids in the development of hypertension. Taken together, these data indicate that correction of IR prevents hypertension, BP variability, and microalbuminuria in obese mice. Although the mechanism remains to be fully determined, increases in aldosterone or sympathoactivation of the cardiovascular system seem to be less likely contributors.

AB - Obesity is a major risk factor for hypertension. The copresentation of hypertension and insulin resistance (IR) suggests a role for IR in blood pressure (BP) dysregulation. To test this hypothesis, peripheral IR has been genetically subtracted in a model of obesity by crossing leptin receptor mutant mice (KdbHPTP) with mice lacking protein tyrosine phosphatase 1B (insulin desensitizer, HdbKPTP) to generate obese insulin-sensitive mice (KdbKPTP). BP was recorded in lean (HdbHPTP, HdbKPTP) and obese (KdbHPTP, KdbKPTP) mice via telemetry, and a frequency analysis of the recording was performed to determine BP variability. Correction of IR in obese mice normalized BP values to baseline levels (HdbHPTP: 116±2 mm Hg; KdbHPTP: 129±4 mm Hg; KdbKPTP: 114±5 mm Hg) and restored BP variability by decreasing its standard deviation and the frequency of BP values over the upper autoregulatory limit of the kidneys. However, although IR-induced increases in proteinuria (versus 53±13 μg/d, HdbHPTP) were corrected in KdbKPTP (112±39 versus 422±159 μg/d, KdbHPTP), glomerular hypertrophy was not. IR reduced plasma aldosterone levels ruling out a role for mineralocorticoids in the development of hypertension. Taken together, these data indicate that correction of IR prevents hypertension, BP variability, and microalbuminuria in obese mice. Although the mechanism remains to be fully determined, increases in aldosterone or sympathoactivation of the cardiovascular system seem to be less likely contributors.

KW - aldosterone

KW - db/db mice

KW - obese mice

KW - pressure variability

UR - http://www.scopus.com/inward/record.url?scp=84868207626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868207626&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.112.196295

DO - 10.1161/HYPERTENSIONAHA.112.196295

M3 - Article

C2 - 23045458

AN - SCOPUS:84868207626

VL - 60

SP - 1273

EP - 1279

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -